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Background: Failure of saphenous vein grafts (SVG) used in CABG is associated with increased rates of late major adverse cardiac events: these 
include death, myocardial infarction and need for revascularization. In the last 10 years endoscopic vein harvest (EVH) has become the preferred 
method of venous conduit procurement in the United States, due to the reduced rates of leg wound healing complications. However, sub analysis 
from both the PREVENT and ROOBY Trials have identified increased rates of late (>6 months) SVG failure compared with open vein harvest (OVH). We 
report the results of a meta-analysis of the available long-term SVG patency studies. 
Methods: A literature search (1996 to 2011) identified 5 observational studies with angiographically documented long-term SVG patency (one 
year in four studies and nine months in one study) for both EVH and OVH vein grafts used for CABG. SVG failure was expressed as the combination of 
angiographic occlusion and severe stenosis (Fitzgibbon grades B+O). A forest plot was constructed. 
Results: There were a total of 6,866 graft assessed by angiography in the five pooled studies. There was some heterogeneity among the pooled 
studies (I2 = 63.7%; 95% CI = 0% - 84.1%). Both random (DerSimonian-Laird) and fixed (Mantel-Haenszel) effects models showed significantly 
lower graft patency with EVH. Given the presence of heterogeneity among the studies, the random effect pooled OR was used to compare EVH with 
OVH. This showed an OR of 1.62 (95% CI = 1.22 - 2.15; p = 0.0009). The fixed effect pooled OR was 1.49 (95% CI = 1.33 - 1.68; p<0.0001). 
Conclusion: Available evidence suggests compromised SVG patency when the conduit was harvested with the EVH technique. A large, multicenter 
prospective randomized clinical trial is warranted to more definitively determine the long-term safety and efficacy of EVH in CABG.
